Axel Bolte

Axel Bolte serves as Chief Executive Officer at Inozyme Pharma. Inozyme Pharma operates in the research sector with approximately 68.0 employees. The company is headquartered in Boston, Massachusetts. Inozyme Pharma generates annual revenue of 76000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 3 executives at Inozyme Pharma.
• • 3,781 executive contacts are available in Massachusetts.
• • Our database includes 201,469 c suite-level executives.

Amazon SES Mimecast Outlook Microsoft Office 365 WP Engine Webflow Salesforce Adobe Marketing Cloud Data Analytics Basis Remote AI

biotechnology: pharmaceutical preparations health care biotechnology research enpp1 deficiency abcc6 deficiency calciphylaxis inz-701 enzyme replacement therapy clinical trials rare diseases ppi-adenosine pathway investigational therapy genetic testing patient registry expanded access mineralization disorders biopharmaceutical healthcare professionals patient education comprehensive support innovative therapeutics phosphate regulation bone health vascular health adenosine regulation patient outcomes medical research community support disease management calcium phosphate clinical development safety & tolerability efficacy assessments medical conditions clinical data therapeutic options healthcare equity personalized healing rare genetic disorders disease progression investor relations scientific research healthcare innovation biotechnology patient testimonies evidence-based approach longitudinal studies healthcare collaboration disease characterization scientific publishing clinical efficacy preventive treatment specialized therapies health wellness & fitness hospital & health care

DT

Doug Treco CEO and Chairman at Inozyme Pharma

MW

Matt Winton Chief Operating Officer at Inozyme Pharma

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

Outreach Guidance — research Sector

Executives like Axel Bolte in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Inozyme Pharma.

Axel Bolte's Position in the MessageCEO Database

• •Axel Bolte is 1 of 3 verified executive contacts we track at Inozyme Pharma.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •3,577 verified executive contacts in Massachusetts are in the database.
• •25 verified contacts work at research companies in the 68.0 employee range (same size as Inozyme Pharma).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated May 2026.

How do I reach Axel Bolte directly?

Axel Bolte's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at Inozyme Pharma. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Axel Bolte work for?

Axel Bolte is Chief Executive Officer at Inozyme Pharma, a company in the research sector with 68.0 employees. The company is based in Boston, Massachusetts.

Can I pitch or sell to Axel Bolte?

As Chief Executive Officer at Inozyme Pharma, Axel Bolte is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Axel Bolte directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Axel Bolte in?

Axel Bolte works in the research industry as Chief Executive Officer at Inozyme Pharma. MessageCEO provides verified contact information for executives across all major industries.

Is Axel Bolte's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Axel Bolte's profile is kept up-to-date with the latest available information.

Last updated: May 28, 2026